Home > Insider Trading > Filing (0001179110-13-013101)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
884629	Actavis Inc.	ACT	Pharmaceutical Preparations (2834)	953872914

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1241752	D Charles Ebert	Morris Corporate Center Iii 400 Interpace Parkway Parsippany NJ 07054	Sr. Vp, Research & Development	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0033	Disposition	2013-08-05	8,244	$136.25	19,970	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Includes shares of restricted stock issued pursuant to the Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Actaivs, Inc., as amended.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.25 to $136.2501, inclusive. The reporting person undertakes to provide to Actavis, Inc., any security holder of Actavis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
This amendment to Form 4 is filed solely to correct the transaction code in Box 3 to reflect a sale rather than a forteiture of shares on the transaction date.